Annovis Bio Secures Patent for Landmark TBI Treatment
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has made a significant leap in the field of neurodegenerative disease treatment with the issuance of a U.S. patent for its lead …
Annovis Bio Secures Patent for Landmark TBI Treatment Read More